A new study co-authored by Mario Castro, MD, suggests a targeted cancer drug called imatinib (Gleevec) may help some patients with severe asthma who do not respond to standard therapy. Read the full story on the School of Medicine’s site »
A new study co-authored by Mario Castro, MD, suggests a targeted cancer drug called imatinib (Gleevec) may help some patients with severe asthma who do not respond to standard therapy. Read the full story on the School of Medicine’s site »